LONDON--(BUSINESS WIRE)--Technavio has been monitoring the contract development and manufacturing organization (CDMO) outsourcing market and it is poised to grow by USD 44.17 billion during 2020-2024, ...

Biopharmaceuticals Contract Manufacturing Market By Source (Mammalian, Non-mammalian), By Service (Process Development [Downstream, Upstream], Fill & Finish Operations, Analytical & QC Studies, ...

The "mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report By Indication (Metabolic & Genetic Diseases), By Application, By End Use, By Region ...

Akari Therapeutics, Plc, an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

DURHAM, N.C. & CARLSBAD, Calif.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Argonaut Manufacturing ...

Dublin, April 29, 2020 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2020-30: Covid 19 Impact and Recovery" report has been ...

Les Mintzmyer is a Sr. Biologics Manufacturing Consultant at Design Space InPharmatics. Today, Les joins the show to share his experience as a leader in the field of bio-pharmaceutical manufacturing.

As a biosecurity crackdown on certain Chinese pharma service providers gains momentum in Washington, the industry trade group Biotechnology Innovation Organization (BIO) is warning U.S. lawmakers that ...

Symbiosis Pharmaceutical Services, a sterile fill finish contract manufacturing organization (CMO), has manufactured its first 10,000 vial batch at the company’s new facility in Stirling, UK.

CHATHAM, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development ...

Chinese life science contracting giant WuXi AppTec is taking another step to zero in on its core offerings by hiving off two China-based subsidiaries. The Shanghai-based corporation announced on Oct.

With more sophisticated therapeutics comes larger and more complex data sets. The complexity is heightened with the advancements in personalized medicine as it introduces new data points at apheresis ...